We identified 16 culture-confirmed cases of A. baumannii with an apparent increase in August 2022. Of the five cases reported in the cluster, MDR-AB was cultured from CSF (n=3), blood culture (n=1) and endotracheal aspirate (n=1). The five cases had a median age of 21 days (interquartile range [IQR]:14–35 days), a median birth weight of 1170 grams (IQR:1000–1530 grams). All five cases had predisposing conditions, including low birthweight (n=4) and congenital pneumonia (n=1). The case-fatality ratio was 80% (4/5). The CSF specimens from three cases were bloodstained indicating possible contamination from blood. All five isolates were phenotypically resistant to tested antimicrobial agents including the carbapenems, but were susceptible to tigecycline and colistin. WGS analysis identified one major cluster of four closely-related isolates with sequence type (ST)-2. Exceeding bed occupancy, shortage of equipment, poor waste management and non-adherence to staffing norms were highlighted in the observational assessment. 